STOCK TITAN

Certara to Present at the BofA Securities 2021 Virtual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Certara, Inc. (Nasdaq: CERT), a leader in biosimulation, announced its participation in the BofA Securities 2021 Virtual Health Care Conference. The presentation will be led by CEO William Feehery and CFO Andrew Schemick on May 11, 2021, at 2:45 p.m. ET. A live webcast will be available on Certara’s investor relations website, with a replay option for 90 days. Certara specializes in accelerating drug discovery and development through innovative biosimulation technology, serving over 1,650 clients globally, including major biopharmaceutical firms and regulatory agencies.

Positive
  • None.
Negative
  • None.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will be participating in the BofA Securities 2021 Virtual Health Care Conference.

William Feehery, CEO, and Andrew Schemick, CFO, are scheduled to present on Tuesday, May 11, 2021 at 2:45 p.m. ET. A live webcast will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter.

About Certara

Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

FAQ

What is Certara's participation in the BofA Securities 2021 Virtual Health Care Conference?

Certara will present at the BofA Securities 2021 Virtual Health Care Conference on May 11, 2021.

When will Certara present at the BofA Conference?

Certara's presentation is scheduled for May 11, 2021, at 2:45 p.m. ET.

How can I watch Certara's presentation at the BofA Conference?

The presentation will be available via a live webcast on Certara’s investor relations website.

What is Certara's expertise in the biopharmaceutical industry?

Certara specializes in biosimulation to enhance drug discovery and development processes.

How many clients does Certara serve?

Certara serves over 1,650 clients, including biopharmaceutical companies and regulatory agencies across 61 countries.

Certara, Inc.

NASDAQ:CERT

CERT Rankings

CERT Latest News

CERT Stock Data

1.77B
120.30M
2.6%
95.94%
3.33%
Health Information Services
Services-prepackaged Software
Link
United States of America
RADNOR